JP2014506577A5 - - Google Patents

Download PDF

Info

Publication number
JP2014506577A5
JP2014506577A5 JP2013553538A JP2013553538A JP2014506577A5 JP 2014506577 A5 JP2014506577 A5 JP 2014506577A5 JP 2013553538 A JP2013553538 A JP 2013553538A JP 2013553538 A JP2013553538 A JP 2013553538A JP 2014506577 A5 JP2014506577 A5 JP 2014506577A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
acceptable salt
indol
pyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013553538A
Other languages
English (en)
Japanese (ja)
Other versions
JP5931929B2 (ja
JP2014506577A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/024428 external-priority patent/WO2012109415A1/en
Publication of JP2014506577A publication Critical patent/JP2014506577A/ja
Publication of JP2014506577A5 publication Critical patent/JP2014506577A5/ja
Application granted granted Critical
Publication of JP5931929B2 publication Critical patent/JP5931929B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013553538A 2011-02-11 2012-02-09 カテプシンc阻害剤 Expired - Fee Related JP5931929B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161441840P 2011-02-11 2011-02-11
US61/441,840 2011-02-11
PCT/US2012/024428 WO2012109415A1 (en) 2011-02-11 2012-02-09 Cathepsin c inhibitors

Publications (3)

Publication Number Publication Date
JP2014506577A JP2014506577A (ja) 2014-03-17
JP2014506577A5 true JP2014506577A5 (https=) 2015-03-05
JP5931929B2 JP5931929B2 (ja) 2016-06-08

Family

ID=46638952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013553538A Expired - Fee Related JP5931929B2 (ja) 2011-02-11 2012-02-09 カテプシンc阻害剤

Country Status (24)

Country Link
US (2) US8841463B2 (https=)
EP (1) EP2672821B9 (https=)
JP (1) JP5931929B2 (https=)
KR (1) KR20140048857A (https=)
CN (1) CN103491777B (https=)
AR (1) AR085163A1 (https=)
AU (1) AU2012214405B2 (https=)
BR (1) BR112013020510A2 (https=)
CA (1) CA2827157A1 (https=)
CL (1) CL2013002325A1 (https=)
CO (1) CO6741219A2 (https=)
DO (1) DOP2013000182A (https=)
EA (1) EA023168B1 (https=)
ES (1) ES2583091T3 (https=)
IL (1) IL227814A0 (https=)
MA (1) MA34961B1 (https=)
MX (1) MX2013009279A (https=)
PE (1) PE20140999A1 (https=)
PH (1) PH12013501665A1 (https=)
SG (1) SG192669A1 (https=)
TW (1) TW201302736A (https=)
UY (1) UY33905A (https=)
WO (1) WO2012109415A1 (https=)
ZA (1) ZA201306074B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014091443A1 (en) 2012-12-13 2014-06-19 Glaxo Group Limited Cathepsin c inhibitors for treating cystic fibrosis, non-cystic fibrosis bronchiectasis, and anca-associated vasculitis
NO2699580T3 (https=) 2014-01-24 2018-02-24
EA201891674A1 (ru) * 2016-02-12 2019-01-31 Фармаксис Лтд. Ингибиторы лизилоксидаз, представляющие собой индольные и азаиндольные производные галогеналлиламина, и их применения
AU2023296161A1 (en) 2022-06-13 2025-01-02 Alivexis, Inc. Azacycloalkyl carbonyl cyclic amine compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2622581B1 (fr) * 1987-11-03 1990-02-16 Inorgan Sa Rech Develop Pharm Nouveaux derives de l-proline, leur preparation et leurs applications biologiques
CN1240355A (zh) * 1996-05-01 2000-01-05 伊莱利利公司 蛋白激酶c抑制剂增强溶癌剂和放射治疗的临床功效的用途
US6232299B1 (en) 1996-05-01 2001-05-15 Eli Lilly And Company Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
US6214799B1 (en) 1996-05-14 2001-04-10 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
US20020107266A1 (en) 2000-12-12 2002-08-08 Marguerita Lim-Wilby Compounds, compositions and methods for treatment of parasitic infections
AU2008237660B2 (en) * 2007-04-12 2011-12-22 Pfizer Inc. 3-amido-pyrrolo [3, 4-C] pyrazole-5 (1H, 4H, 6H) carbaldehyde derivatives as inhibitors of protein kinase C
MX2011011661A (es) * 2009-05-07 2011-11-18 Astrazeneca Ab Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
UY32827A (es) * 2009-08-12 2011-02-28 Glaxo Group Ltd Inhibidores de catepsina c
WO2012119941A1 (en) 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors

Similar Documents

Publication Publication Date Title
JP2014500861A5 (https=)
JP2013519675A5 (https=)
JP2013509429A5 (https=)
JP2013519645A5 (https=)
JP2011518833A5 (https=)
JP2013525444A5 (https=)
JP2019524883A5 (https=)
JP2017537066A5 (https=)
JP2013542261A5 (https=)
JP2015508103A5 (https=)
JP2015024998A5 (https=)
JP2013542247A5 (https=)
JP2015512931A5 (https=)
JP2014511891A5 (https=)
JP2013032389A5 (https=)
JP2013534248A5 (https=)
JP2014515013A5 (https=)
JP2015537020A5 (https=)
JP2011529054A5 (https=)
JP2008501000A5 (https=)
JP2014521744A5 (https=)
JP2016540749A5 (https=)
JP2017517565A5 (https=)
JP2011246469A5 (https=)
JP2016522254A5 (https=)